Stockscreener 앱 받기
29.75
0.44%
-0.13
전일 마감가:
$29.88
열려 있는:
$29.3
하루 거래량:
405.55K
Relative Volume:
0.79
시가총액:
$1.36B
수익:
$604.93M
순이익/손실:
$-31.91M
주가수익비율:
-12.29
EPS:
-2.42
순현금흐름:
$45.67M
1주 성능:
+1.29%
1개월 성능:
-2.78%
6개월 성능:
+10.43%
1년 성능:
-30.21%
1일 변동 폭
$29.17
$30.04
1주일 범위
$29.17
$31.16
52주 변동 폭
$23.91
$55.63
Azenta Inc Stock (AZTA) Company Profile
명칭
Azenta Inc
전화
(978) 262-2400
주소
200 SUMMIT DRIVE, BURLINGTON
AZTA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AZTA
Azenta Inc
|
29.75 | 1.37B | 604.93M | -31.91M | 45.67M | -2.42 |
|
ISRG
Intuitive Surgical Inc
|
549.51 | 200.47B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
193.04 | 55.33B | 21.84B | 1.68B | 2.67B | 5.8322 |
|
ALC
Alcon Inc
|
77.65 | 38.61B | 10.19B | 1.05B | 1.39B | 2.1065 |
|
RMD
Resmed Inc
|
244.46 | 36.80B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
WST
West Pharmaceutical Services Inc
|
261.36 | 19.18B | 2.96B | 487.70M | 344.00M | 6.6758 |
Azenta Inc Stock (AZTA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-30 | 업그레이드 | Jefferies | Hold → Buy |
| 2025-08-06 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2025-07-22 | 재개 | Stephens | Equal-Weight |
| 2024-12-18 | 업그레이드 | Stephens | Equal-Weight → Overweight |
| 2024-04-04 | 개시 | Jefferies | Hold |
| 2024-02-01 | 재확인 | B. Riley Securities | Buy |
| 2023-07-19 | 개시 | Raymond James | Mkt Perform |
| 2023-05-10 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-02-09 | 다운그레이드 | Stephens | Overweight → Equal-Weight |
| 2023-01-03 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2022-03-31 | 재개 | B. Riley Securities | Buy |
| 2022-03-21 | 개시 | Evercore ISI | Outperform |
모두보기
Azenta Inc 주식(AZTA)의 최신 뉴스
Why institutional investors increase stakes in Azenta Inc. (BA3) stockJuly 2025 Recap & Free Daily Entry Point Trade Alerts - newser.com
How Azenta Inc. (BA3) stock responds to job market shiftsQuarterly Trade Summary & Weekly Top Gainers Trade List - newser.com
Using data models to predict Azenta Inc. stock movementMarket Weekly Review & Step-by-Step Trade Execution Guides - newser.com
Is Azenta Inc. (BA3) stock at risk of policy regulationQuarterly Market Summary & Safe Capital Allocation Plans - newser.com
How Azenta Inc. (BA3) stock compares with tech leadersWeekly Trade Review & Free High Accuracy Swing Entry Alerts - newser.com
Backtesting results for Azenta Inc. trading strategiesWeekly Market Summary & Reliable Breakout Stock Forecasts - newser.com
Is Azenta Inc. stock a buy in volatile marketsEarnings Summary Report & High Yield Equity Trading Tips - newser.com
Can Azenta Inc. (BA3) stock sustain margin levels2025 Investor Takeaways & Real-Time Sentiment Analysis - newser.com
Should I hold or sell Azenta Inc. stock in 2025Earnings Performance Report & Free Community Supported Trade Ideas - newser.com
Why Azenta Inc. stock is popular among millennialsJuly 2025 Sector Moves & Fast Entry and Exit Trade Plans - newser.com
Using data tools to time your Azenta Inc. exitAnalyst Upgrade & Advanced Swing Trade Entry Plans - newser.com
Is Azenta Inc. (BA3) stock a top hedge fund pickWeekly Trade Review & Free Technical Confirmation Trade Alerts - newser.com
Is Azenta Inc. stock oversold or undervaluedJuly 2025 Setups & High Accuracy Swing Trade Signals - Fundação Cultural do Pará
Is Azenta Inc. stock vulnerable to regulatory risks2025 Valuation Update & Trade Opportunity Analysis Reports - newser.com
Will Azenta Inc. stock keep outperforming rivalsMarket Trend Report & High Return Trade Guides - newser.com
Pancreatic Cancer Research Partnership Could Be a Game Changer for Azenta (AZTA) - simplywall.st
Why Azenta Inc. (BA3) stock appeals to dividend investorsJuly 2025 Rallies & Real-Time Volume Spike Alerts - newser.com
Azenta Announces Fiscal 2025 Fourth Quarter and Full Year Conference Call and Webcast - Eastern Progress
Long term hold vs stop loss in Azenta Inc.Quarterly Trade Report & Verified Momentum Stock Alerts - newser.com
Live market analysis of Azenta Inc.Product Launch & Fast Exit/Entry Strategy Plans - newser.com
Azenta (Nasdaq: AZTA) sets earnings call for Q4 and full-year results on Nov. 21 - Stock Titan
Azenta, Inc. Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo
Azenta Inc (AZTA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Azenta Inc 주식 (AZTA) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Lin Lawrence Y. | EVP, CFO and Treasurer |
Aug 11 '25 |
Buy |
27.96 |
2,500 |
69,900 |
46,013 |
| Hughes Violetta | VP, Chief Accounting Officer |
Feb 03 '25 |
Sale |
52.97 |
317 |
16,791 |
9,603 |
| Zhou Ginger | SVP and General Manager, Genom |
Jan 31 '25 |
Buy |
45.88 |
417 |
19,132 |
27,916 |
| Pirogova Olga | SVP and CHRO |
Nov 19 '24 |
Sale |
40.07 |
548 |
21,958 |
19,373 |
| Hughes Violetta | VP, Chief Accounting Officer |
Nov 19 '24 |
Sale |
40.07 |
163 |
6,531 |
9,920 |
| Zhou Ginger | SVP and General Manager, Genom |
Nov 19 '24 |
Sale |
40.07 |
491 |
19,674 |
27,499 |
| Wang David Dong | SVP & GM, SMS |
Nov 19 '24 |
Sale |
40.07 |
348 |
13,944 |
24,114 |
| Joseph Jason | SVP, General Counsel, Secy. |
Nov 19 '24 |
Sale |
40.07 |
1,139 |
45,640 |
112,564 |
| Cueto Herman | EVP, Chief Financial Officer |
Nov 19 '24 |
Sale |
40.07 |
712 |
28,530 |
23,892 |
| Marotta John | President and CEO |
Nov 18 '24 |
Buy |
39.48 |
12,717 |
502,066 |
99,612 |
1.23%
0.58%
자본화:
|
볼륨(24시간):